Scope and Purpose
ISO 15378 establishes quality management system requirements specifically for manufacturers of primary packaging materials for medicinal products, building directly on the ISO 9001 general quality management framework while adding pharmaceutical-specific requirements addressing product contact material safety, contamination control, and other considerations genuinely specific to packaging materials that will come into direct contact with pharmaceutical products. This standard addresses a genuine gap ISO 9001 alone leaves open, since ISO 9001's general, industry-agnostic framework does not specifically address the particular quality considerations relevant to material that will directly contact a pharmaceutical product and therefore carries genuine potential to affect that product's own safety and quality.
Additional GMP Requirements
Beyond core ISO 9001 requirements, ISO 15378 adds specific expectations addressing Good Manufacturing Practice principles applied to packaging material production, including contamination control appropriate to product-contact material manufacturing, change control specifically addressing packaging material formulation or process changes, and risk management applied specifically to packaging-material-related risks relevant to the medicinal products the packaging will ultimately contain. These additional GMP-oriented requirements reflect genuine recognition that packaging material manufacturing, while conceptually related to general manufacturing quality management, carries specific additional considerations warranting dedicated, packaging-specific attention beyond what a purely general quality management system addresses.
Applicability
ISO 15378 applies specifically to primary packaging materials, meaning packaging in direct contact with the medicinal product itself, such as blister foil, vial glass, or closure components, rather than secondary or tertiary packaging serving purely protective or informational functions without direct product contact. This scope distinction matters for correctly determining which specific packaging material suppliers genuinely warrant ISO 15378-level evaluation versus suppliers of secondary packaging materials for whom a more general ISO 9001-level quality expectation may reasonably suffice given their materials' lack of direct product contact.
Supplier Selection Use
Pharmaceutical companies increasingly favor or specifically require ISO 15378 certification, or equivalent demonstrated compliance, when qualifying primary packaging material suppliers, using certification as valuable supporting evidence within the broader supplier qualification program discussed elsewhere in this collection, though genuine direct evaluation of the specific supplier and specific material remains important even where ISO 15378 certification exists, since certification confirms general quality system adequacy rather than guaranteeing every specific material or product line automatically meets every specific pharmaceutical customer's own particular additional requirements.
Relationship to Direct Pharmaceutical Company Auditing
ISO 15378 certification can meaningfully reduce, though rarely entirely eliminate, the depth of independent audit a pharmaceutical company might otherwise need to conduct for a primary packaging material supplier, since certified compliance with this pharmaceutical-specific standard provides considerably stronger relevant assurance than general ISO 9001 certification alone would provide for this particular, product-contact-relevant material category.
Change Control Expectations Under ISO 15378
ISO 15378's change control requirements specifically address how a packaging material manufacturer should evaluate and communicate changes to material formulation, manufacturing process, or facility that could affect the material's suitability for its pharmaceutical customer's intended use, connecting directly to the pharmaceutical customer's own change control processes discussed in the related change control article, since a packaging supplier's own change potentially requires the receiving pharmaceutical company's own change evaluation and, in some cases, additional stability or compatibility testing before the changed material can be accepted for continued use.
Certification and Ongoing Compliance
Like other ISO management system standards, ISO 15378 certification requires initial assessment followed by ongoing surveillance audits confirming sustained compliance, and pharmaceutical companies relying on a supplier's certification should periodically confirm continued current certification status rather than assuming indefinite validity based solely on an initial qualification-time verification of certification status.
Leave your rating